LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MDA-MB-231 AZD 5438
10.0
uM
LJP6
3
J01
72
hr
1235 337 4513 0.0747 -0.2743
MDA-MB-231 A443654
10.0
uM
LJP6
3
I19
72
hr
1235 337 4513 0.0747 -0.2743
MDA-MB-231 NVP-TAE684
10.0
uM
LJP6
3
K13
72
hr
1235 338 4513 0.0749 -0.2740
MDA-MB-231 BMS345541
10.0
uM
LJP6
1
D01
72
hr
1235 340 4513 0.0753 -0.2734
Hs 578T Omipalisib
10.0
uM
LJP6
1
N01
72
hr
658 340 3846 0.0884 -0.0998
MCF 10A PHA-793887
10.0
uM
LJP6
3
E19
72
hr
962 341 10605 0.0322 -0.0644
BT-20 Geldanamycin
10.0
uM
LJP5
1
O01
72
hr
1097 341 3769 0.0905 -0.2830
Hs 578T Withaferin A
10.0
uM
LJP6
3
G13
72
hr
658 342 3846 0.0889 -0.0992
MDA-MB-231 CGP60474
10.0
uM
LJP6
1
G01
72
hr
1235 343 4513 0.0760 -0.2724
MDA-MB-231 A443654
10.0
uM
LJP6
2
I19
72
hr
1235 345 4513 0.0764 -0.2718
MCF 10A PF562271
10.0
uM
LJP6
1
F13
72
hr
962 345 10605 0.0325 -0.0640
Hs 578T Omipalisib
10.0
uM
LJP6
3
N01
72
hr
658 347 3846 0.0902 -0.0976
MDA-MB-231 Geldanamycin
10.0
uM
LJP6
1
O01
72
hr
1235 347 4513 0.0769 -0.2712
Hs 578T CGP60474
10.0
uM
LJP5
3
F01
72
hr
658 348 3846 0.0905 -0.0973
MCF 10A Celastrol
3.33
uM
LJP6
3
G08
72
hr
962 349 10605 0.0329 -0.0636
SK-BR-3 AT-7519
10.0
uM
LJP6
1
K01
72
hr
1401 349 4223 0.0826 -0.3730
Hs 578T Fedratinib
10.0
uM
LJP5
3
L01
72
hr
658 349 3846 0.0907 -0.0970
BT-20 LDN-193189
3.33
uM
LJP5
2
G02
72
hr
1097 350 3769 0.0929 -0.2796
MDA-MB-231 A443654
10.0
uM
LJP6
1
I19
72
hr
1235 350 4513 0.0775 -0.2703
Hs 578T A443654
0.37
uM
LJP6
2
I22
72
hr
658 351 3846 0.0913 -0.0964
MDA-MB-231 PHA-793887
10.0
uM
LJP6
1
E19
72
hr
1235 351 4513 0.0778 -0.2700
Hs 578T Fedratinib
10.0
uM
LJP5
1
L01
72
hr
658 352 3846 0.0915 -0.0960
Hs 578T CGP60474
3.33
uM
LJP5
2
F02
72
hr
658 352 3846 0.0915 -0.0960
MDA-MB-231 AT-7519
10.0
uM
LJP6
3
K01
72
hr
1235 352 4513 0.0780 -0.2697
MCF7 JNK-9L
3.33
uM
LJP6
2
K20
72
hr
1209 355 4093 0.0867 -0.2964